VX-659 Uses, Dosage, Side Effects and more
VX-659 is under investigation in clinical trial NCT03224351 (A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis).
| Trade Name | VX-659 |
| Generic | VX-659 |
| Type | |
| Formula | C28H32F3N5O4S |
| Weight | Average: 591.65 Monoisotopic: 591.212710193 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
